An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models

Familial Cancer

Volumn 10, Issue 1, 2011, Pages 133-139

  Choi, Cheuk Wai ^a   Lee, Michael C H ^a   Ng, Wai Tong ^a   Law, Lai Yau ^a   Yau, Tsz Kok ^a   Lee, Anne W M ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Familial risk; Markov chain model; Nasopharyngeal carcinoma; Screening

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FAMILIAL CANCER; HONG KONG; NASOPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROBABILITY; SCREENING TEST; SIMULATION; STATISTICAL MODEL; STATISTICAL PARAMETERS; SURVIVAL RATE; VIRUS REACTIVATION;

ADULT; ANTIBODIES, VIRAL; DISEASE PROGRESSION; DNA, VIRAL; EARLY DIAGNOSIS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MARKOV CHAINS; MASS SCREENING; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TIME FACTORS;

HUMAN HERPESVIRUS 4;

EID: 79951850748     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9397-7     Document Type: Article

References (17)

1. Y Zeng LG Zhang HY Li, et al. 1982 Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China Int J Cancer 29 2 139 141 1:STN:280:DyaL387ktFWqtQ%3D%3D 10.1002/ijc.2910290204 6895884 (Pubitemid 12166994)
2. Y Zeng LG Zhang YC Wu, et al. 1985 Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China Int J Cancer 36 5 545 547 1:STN:280:DyaL28%2Fjt1Clug%3D%3D 10.1002/ijc.2910360505 4055129 (Pubitemid 16233512)
3. Y Zeng JM Zhong LY Li, et al. 1983 Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China Intervirology 20 4 190 194 1:STN:280:DyaL2c%2Foslaisg%3D%3D 10.1159/000149391 6317603 (Pubitemid 14237237)
4. YS Zong JS Sham MH Ng, et al. 1992 Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma Cancer 69 1 3 7 1:STN:280:DyaK38%2FovFymtQ%3D%3D 10.1002/1097-0142(19920101)69:1<3::AID- CNCR2820690104>3.0.CO;2-7 1309307
5. JY Chen CJ Chen MY Liu, et al. 1989 Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan J Med Virol 27 4 269 273 1:STN:280: DyaL1M3lslejsw%3D%3D 10.1002/jmv.1890270403 2542436 (Pubitemid 19125780)
6. WT Ng TK Yau RW Yung, et al. 2005 Screening for family members of patients with nasopharyngeal carcinoma Int J Cancer 113 6 998 1001 1:CAS:528:DC%2BD2MXnvFCnsA%3D%3D 10.1002/ijc.20672 15515016 (Pubitemid 40096880)
7. HH Chen TC Prevost SW Duffy 1999 Evaluation of screening for nasopharyngeal carcinoma: trial design using Markov chain models Br J Cancer 79 11-12 1894 1900 1:STN:280:DyaK1M3itFWmsw%3D%3D 10.1038/sj.bjc.6690301 10206310 (Pubitemid 29132321)
8. GJ van Oortmarssen R Boer JD Habbema 1995 Modelling issues in cancer screening Stat Methods Med Res 4 1 33 54 10.1177/096228029500400104 7613637
9. GJ van Oortmarssen JD Habbema JT Lubbe PJ van der Maas 1990 A model-based analysis of the HIP project for breast cancer screening Int J Cancer 46 2 207 213 10.1002/ijc.2910460211 2384271 (Pubitemid 20252078)
10. WT Ng CW Choi MC Lee LY Law TK Yau AW Lee 2010 Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong Fam Cancer 9 2 221 228 10.1007/s10689-009-9296-y 19779847
11. SW Duffy HH Chen L Tabar NE Day 1995 Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase Stat Med 14 14 1531 1543 1:STN:280:DyaK28%2FgtVynsQ%3D%3D 10.1002/sim.4780141404 7481190
12. AW Lee WM Sze JS Au, et al. 2005 Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 61 4 1107 1116 10.1016/j.ijrobp.2004.07.702 15752890 (Pubitemid 40340904)
13. DP Huang JH Ho W Henle G Henle 1974 Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies Int J Cancer 14 5 580 588 1:CAS:528:DyaE2MXht1ejsLg%3D 10.1002/ijc.2910140504 4142471
14. W Henle G Henle 1977 Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies Laryngoscope 87 4 Pt 1 467 473 1:STN:280:DyaE2s7it12itg%3D%3D 190497
15. MF Ji DK Wang YL Yu, et al. 2007 Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma Br J Cancer 96 4 623 630 1:CAS:528:DC%2BD2sXhvV2jt70%3D 10.1038/sj.bjc.6603609 17285127
16. A Ung CJ Chen PH Levine, et al. 1999 Familial and sporadic cases of nasopharyngeal carcinoma in Taiwan Anticancer Res 19 1B 661 665 1:STN:280:DyaK1M3jt1Wiuw%3D%3D 10216473 (Pubitemid 29168312)
17. KS Loh BC Goh J Lu WS Hsieh L Tan 2006 Familial nasopharyngeal carcinoma in a cohort of 200 patients Arch Otolaryngol Head Neck Surg 132 1 82 85 10.1001/archotol.132.1.82 16415435 (Pubitemid 43127969)